Related Experiment Videos

[Gene therapy in liver diseases]

Alajos Pár1, Péter László Lakatos, Margit Abonyi

  • 1Altalános Orvostudományi Kar, I. sz. Belgyógyászati Klinika, Pécsi Tudományegyetem, Pécs.

Orvosi Hetilap
|March 9, 2002
PubMed

Insights

Gene therapy, including ex vivo and in vivo gene transfers, is a promising approach for treating liver diseases like hepatocellular carcinoma. While still in the preclinical stage, ongoing research suggests its future clinical utility in hepatology.

Area of Science:

  • Molecular Biology
  • Genetics
  • Hepatology

Context:

  • Gene therapy involves introducing genetic material to treat diseases.
  • Ex vivo and in vivo gene transfer methods are key techniques.
  • Hepatocellular carcinoma (HCC) is a significant liver disease.

Purpose:

  • To review the fundamental principles of gene therapy.
  • To examine clinical application models and experimental results for liver diseases, particularly HCC.
  • To assess the current preclinical status and future potential of gene therapy in clinical hepatology.

Summary:

  • This paper reviews gene therapy principles, including ex vivo and in vivo gene transfer methods and various vectors.
  • It presents models for clinical application, highlighting experimental results for liver diseases, especially hepatocellular carcinoma.
  • Gene therapy is currently in the preclinical stage but shows future promise for clinical hepatology.

Impact:

  • Provides a comprehensive overview of gene therapy for liver disease treatment.
  • Highlights the potential of gene therapy in managing hepatocellular carcinoma.
  • Predicts gene therapy's future role in clinical hepatology with ongoing research and problem resolution.

Related Concept Videos